Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Xellar Biosystems
Xellar Biosystems is a wet artificial intelligence biotechnology company that accelerates drug discovery by combining Organ-on-a-Chip technology, multicellular 3D disease model development, and…
Xellar Biosystems
Xellar Biosystems is a wet artificial intelligence biotechnology company that accelerates drug discovery by combining Organ-on-a-Chip technology, multicellular 3D disease model development, and…
TL;DR
What they do: Pharma-scale organ-on-chip platforms combined with high-content imaging and AI/ML for drug discovery
Headquarters / R&D: Boston/Cambridge, MA area (R&D lab at 500 Rutherford Ave, Boston; office at 1 Broadway, Cambridge)
Founders: Xin Xie, PhD (Cofounder & CEO); Hermione He (Cofounder, Strategy & Investor Relations)
Founded: 2022
Recent funding: Seed rounds reported Jul 17, 2024 and Apr 28, 2025
Company Overview
Problem Domain
Preclinical drug discovery and development—improving model relevance and throughput for assessing disease biology and drug responses.
Founded
2022
Industry
Biotechnology
Tech Stack
Funding Track Record
≈100 million CNY (reported)
Reported Jul 17, 2024 seed/angel+ round with multiple investors
Tens of millions of CNY (reported)
Reported Apr 28, 2025 seed/strategic round with participation from XtalPi, Yael Capital, Tiantu Capital
Investor Signal
“Participating investors include XtalPi, TriApex, Tiantu Capital, Legend Capital, Yael Capital Management Limited, Zhengxuan Investment”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
58,000+
Open Roles
2,700+
New This Week
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |